Sweat sensor could replace blood draws for sepsis monitoring

NCT ID NCT07716371

Not yet recruiting Diagnosis Sponsor: Second Affiliated Hospital of Xi'an Jiaotong University Source: ClinicalTrials.gov ↗

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This study tests a wearable device that measures lactate levels in sweat for critically ill patients with sepsis or septic shock. High blood lactate is a key sign of tissue oxygen shortage, but current sweat sensors cannot detect the high levels seen in these patients. The new sensor aims to provide a non-invasive way to track lactate continuously, potentially reducing the need for frequent blood tests.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: a wearable sweat sensor that measures lactate levels in sweat
What this could lead to: If successful, this could enable non-invasive, continuous monitoring of lactate in critically ill patients, potentially replacing frequent blood draws.
What could go wrong: This is an early-stage validation study with only 86 participants, so the sensor may not prove accurate or reliable enough for clinical use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEPSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infectious disease with sepsis Sepsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SEPSIS SEVERE SEPSIS WITH SEPTIC SHOCK SEVERE SEPSIS WITHOUT SEPTIC SHOCK

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.